M Mohammed Ali Elhassan1, A Abdalla Mohamedani2, H Hussein Mohammed Osman3, N Osman Yousif4, N Mohamed Elhaj4, I Qaddoumi5. 1. Department of Oncology, National Cancer Institute, University of Gezira, PO Box 20, Wad Madani, Sudan. moawia2@gmail.com. 2. Department of Pathology, Faculty of Medicine, University of Gezira, Wad Madani, Sudan. 3. Department of Neurosurgery, Faculty of Medicine, The National Ribat University, Khartoum, Sudan. 4. Department of Oncology, National Cancer Institute, University of Gezira, PO Box 20, Wad Madani, Sudan. 5. Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract
PURPOSE: Studies of epidemiology, treatment modalities, and outcomes of childhood central nervous system (CNS) tumors in Sudan are scarce. To address this shortcoming, we evaluated baseline information about the epidemiology, treatment types, and outcomes of childhood CNS tumors at the National Cancer Institute, University of Gezira (NCI-UG) in Wad Madani, Sudan. METHODS: We performed a retrospective health facility-based study of children with CNS tumors who were treated at the NCI-UG from January 2000 to December 2015. RESULTS: A total of 62 (5.4% of all childhood cancers) pediatric patients with CNS tumors were identified over the study period. Tumors were more common among male children and involved the infratentorial compartment in 58% of cases. The median age at diagnosis was 9 years (range, 2-14 years). Approximately 60% (n = 37) of the study population had histology-determined diagnoses. Astrocytomas and medulloblastomas were the most common tumors in these cases. The mean time to diagnosis was 6 months (SD, 9). During the study period, the number of children with CNS tumors who were referred for treatment at the NCI-UG increased every year. Of the 37 patients who received surgical interventions, 8 received gross total resections, 20 received partial resections, and 24 received postoperative radiotherapy. The treatment abandonment rate was 11%. The 2-year and 5-year survival rates were 33% and 13%, respectively. CONCLUSION: Our findings reveal a high incidence of poor outcomes for patients with CNS tumors in Sudan, which is most likely due to many distinct factors.
PURPOSE: Studies of epidemiology, treatment modalities, and outcomes of childhood central nervous system (CNS) tumors in Sudan are scarce. To address this shortcoming, we evaluated baseline information about the epidemiology, treatment types, and outcomes of childhood CNS tumors at the National Cancer Institute, University of Gezira (NCI-UG) in Wad Madani, Sudan. METHODS: We performed a retrospective health facility-based study of children with CNS tumors who were treated at the NCI-UG from January 2000 to December 2015. RESULTS: A total of 62 (5.4% of all childhood cancers) pediatric patients with CNS tumors were identified over the study period. Tumors were more common among male children and involved the infratentorial compartment in 58% of cases. The median age at diagnosis was 9 years (range, 2-14 years). Approximately 60% (n = 37) of the study population had histology-determined diagnoses. Astrocytomas and medulloblastomas were the most common tumors in these cases. The mean time to diagnosis was 6 months (SD, 9). During the study period, the number of children with CNS tumors who were referred for treatment at the NCI-UG increased every year. Of the 37 patients who received surgical interventions, 8 received gross total resections, 20 received partial resections, and 24 received postoperative radiotherapy. The treatment abandonment rate was 11%. The 2-year and 5-year survival rates were 33% and 13%, respectively. CONCLUSION: Our findings reveal a high incidence of poor outcomes for patients with CNS tumors in Sudan, which is most likely due to many distinct factors.
Authors: Moawia Mohammed Ali Elhassan; Haytham Hussein Mohammed Osman; Jeannette Parkes Journal: Childs Nerv Syst Date: 2017-04-21 Impact factor: 1.475
Authors: F Gjerris; N Agerlin; S E Børgesen; L Buhl; J Haase; L Klinken; A C Mortensen; J H Olsen; N Ovesen; E Reske-Nielsen; K Schmidt Journal: Childs Nerv Syst Date: 1998-07 Impact factor: 1.475
Authors: Scott C Howard; Monika L Metzger; Judith A Wilimas; Yuri Quintana; Ching-Hon Pui; Leslie L Robison; Raul C Ribeiro Journal: Cancer Date: 2008-02-01 Impact factor: 6.860
Authors: Paola Friedrich; Catherine G Lam; Geetinder Kaur; Elena Itriago; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2016-10-13 Impact factor: 3.240
Authors: Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata Journal: Pathol Oncol Res Date: 2020-07-13 Impact factor: 2.874
Authors: Dragana Stanić; Danica Grujičić; Tatjana Pekmezović; Jelena Bokun; Marija Popović-Vuković; Dragana Janić; Lejla Paripović; Vesna Ilić; Marija Pudrlja Slović; Rosanda Ilić; Savo Raičević; Milan Sarić; Ivana Mišković; Borko Nidžović; Marina Nikitović Journal: PLoS One Date: 2021-10-26 Impact factor: 3.240